This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
HAYES, Inc.. High-frequency left repetitive transcranial magnetic stimulation for treatment-resistant major depressive disorder
. Lansdale: HAYES, Inc.. Directory Publication. 2016
Repetitive high-frequency left transcranial magnetic stimulation (HFL-rTMS) is a noninvasive technique that may serve as an alternative intervention for treatment-resistant depression (TRD). Brief repetitive pulses of magnetic energy are applied to the scalp via a large electromagnetic coil, thereby modulating electrical current in the underlying cortical tissue. The goal of HFL-rTMS is to influence activity in areas of the brain involved in mood regulation, in order to shorten the duration or reduce the severity of depressive episodes. HFL-rTMS may be used to augment current pharmacotherapy or as a primary treatment strategy for medication-free patients.
Rationale: HFLrTMS is a noninvasive treatment for depression and may be an alternative treatment for patients
with TRD. The procedure is associated with minimal side effects, generally does not induce seizures, and can be performed in an outpatient setting.
Relevant Questions: Does HFL-rTMS effectively relieve depression symptoms for patients with TRD? Does HFL-rTMS result in acceptable response and remission rates in patients with TRD? Is repetitive transcranial magnetic stimulation (rTMS) safe? Have definitive patient selection criteria been established for rTMS for
Subject indexing assigned by CRD
Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Prefrontal Cortex; Transcranial Magnetic Stimulation
Country of organisation
An English language summary is available.
Address for correspondence
HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: firstname.lastname@example.org
Date abstract record published